Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species

被引:79
作者
Shen, P.
Guo, B. L.
Gong, Y.
Hong, Deborah Y. Q.
Hong, Y.
Yong, E. L.
机构
[1] Natl Univ Singapore Hosp, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 119074, Singapore
[2] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China
[3] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 119074, Singapore
关键词
Epimedium species; Berberidaceae; taxonomy; genetic; chemical; estrogenic activity;
D O I
10.1016/j.phytochem.2007.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To understand the factors contributing to estrogenic properties of extracts from the genus Epimedium L. (Berberidaceae), we performed taxonomic, genetic and chemical characterization on 37 specimens from 18 species and related these to estrogen receptor (ER alpha and ERP) bioactivity, as measured by reporter genes in stable human cells. Boot strap values derived from amplified fragment length polymorphisms indicated that specimens of E. koreanum, E. brevicornum, E. myrianthum, E. leishanense, and E. membranaceum were genetically distinct and this was supported by their very similar ER alpha activities. In contrast, specimens from E. pubescens and E. sagittatum were diverse both genetically, chemically and in terms of ER alpha and ERP bioactivities. Strikingly, a genetic cluster comprising six rare Epimedium species exhibited strongest ER alpha and ERP activity, and this bioactivity was positively correlated with content of trace flavonoid aglycones (kaempferol, apigenin, quercetin, luteolin and breviflavone B). In contrast, there was no association between estrogenic activity and the major flavonol glycoside constituents (icariin and epimedin A-C). Although they exhibited equally strong ER alpha and ERP activity, E. koreanum can be clearly differentiated from E. pubeseens and E. brevicornum by genetic distance and its significantly lower content of epimedin C. Our morphologic, genetic, chemical and bioactivity profiling provide the basis for the production of extracts with reproducible estrogenic properties. Such reproducibility will be critical for the standardization of Epimedium-based products. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1448 / 1458
页数:11
相关论文
共 30 条
[11]   Characterization of flavonoids in extracts from four species of Epimedium by micellar electrokinetic capillary chromatography with diode-array detection [J].
Liang, HR ;
Siren, H ;
Jyske, P ;
Reikkola, ML ;
Vuorela, P ;
Vuorela, H ;
Hiltunen, R .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1997, 35 (03) :117-125
[12]   Dimeric progestins from rhizomes of Ligusticum chuanxiong [J].
Lim, LS ;
Shen, P ;
Gong, YH ;
Yong, EL .
PHYTOCHEMISTRY, 2006, 67 (07) :728-734
[13]   Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design [J].
Liu, JJ ;
Li, SP ;
Wang, YT .
JOURNAL OF CHROMATOGRAPHY A, 2006, 1103 (02) :344-349
[14]   Mining the complexities of the estrogen signaling pathways for novel therapeutics [J].
McDonnell, DP .
ENDOCRINOLOGY, 2003, 144 (10) :4237-4240
[15]   Osteoblastic proliferative activity of Epimediuim brevicornum Maxim. [J].
Meng, FH ;
Li, YB ;
Xiong, ZL ;
Jiang, ZM ;
Li, FM .
PHYTOMEDICINE, 2005, 12 (03) :189-193
[16]   The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids [J].
Milligan, SR ;
Kalita, JC ;
Pocock, V ;
Van de Kauter, V ;
Stevens, JF ;
Deinzer, ML ;
Rong, H ;
De Keukeleire, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4912-4915
[17]   SEASONAL FLUCTUATION OF FLAVONOL GLYCOSIDES IN EPIMEDIUM SPECIES [J].
MIZUNO, M ;
IINUMA, M ;
TANAKA, T ;
IWASHIMA, S ;
SAKAKIBARA, N .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1989, 109 (04) :271-273
[18]  
Nakai R, 1996, BIOL PHARM BULL, V19, P67, DOI 10.1248/bpb.19.67
[19]  
PEDRO M, 2005, TOXICOL LETT 1217
[20]   Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].
Rossouw, JE ;
Anderson, GL ;
Prentice, RL ;
LaCroix, AZ ;
Kooperberg, C ;
Stefanick, ML ;
Jackson, RD ;
Beresford, SAA ;
Howard, BV ;
Johnson, KC ;
Kotchen, JM ;
Ockene, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333